(Q33393995)

English

Plasma cell leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

Plasma cell leukemia (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

object named as

Rafael Fonseca

2

0 references

author name string

Flavio Albarracin

1

1 reference

Europe PubMed Central

26 July 2017

publication date

3 February 2011

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

25

1 reference

Europe PubMed Central

26 July 2017

107-112

1 reference

Europe PubMed Central

26 July 2017

3

1 reference

Europe PubMed Central

26 July 2017

Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Genetic aberrations and survival in plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Clinical significance of TP53 mutation in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Bortezomib is an efficient agent in plasma cell leukemias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Primary plasma cell leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Plasma cell leukemia. Report on 17 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Plasma cell leukemia: an evaluation of response to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

21 June 2018

Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Plasma cell leukemia: a rare condition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone - a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Genetics and cytogenetics of multiple myeloma: a workshop report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Thalidomide Administration for the Treatment of Resistant Plasma Cell Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Clinical and biologic implications of recurrent genomic aberrations in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3907188

31 October 2018

Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of bortezomib in patients with plasma cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hé

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-RAS and K-RAS gene mutations in Brazilian patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib is effective in primary plasma cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant

1 reference

https://pubmed.ncbi.nlm.nih.gov/21295388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BLRE.2011.01.005

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393995&oldid=1617927502"